Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 December 2018 | Story Leonie Bolleurs | Photo Barend Nagel
Marcelle Vermeulen
Marcele Vermeulen, a graduate from the Department of Plant Sciences, explores possible threats to crop production; contributing to food security in South Africa.

Global food security is currently threatened both by climate change and the low diversity of crops relied on by humankind to feed a growing world population. Marcele Vermeulen, a graduate in the Department of Plant Sciences who will receive her PhD at the December graduation ceremonies at the University of the Free State (UFS), is part of a team that is working hard to add to the diversity of staple foods in South Africa.

In the drive to focus on alternative crops, Marcele is researching the crop, Amaranthus cruentus, (grain amaranth). It is more tolerant to environmental stress for large-scale production, thereby also diversifying staple crops.

Relatively new development

“Amaranthus cruentus is an excellent candidate due to its high nutritional value and tolerance to drought and high temperatures. It can be mixed with conventional maize meal, to increase the protein intake of its consumers,” said Marcele.

The production of A. cruentus as a grain crop in South Africa is a relatively new development.

In her research, exploring the possible threats to crop production and paying particular attention to dominant plant pathogens in the Amaranthus cruentus, Marcele found a correlation between fungal pathogens and insect pests. 

Insect pests can influence plant diseases

Although reports on fungal pathogens and pests specific to A. cruentus are limited to and information for South Africa is limited to this study, there is a possibility that by controlling insect pests such as weevils, one might also be able to control fungal pathogens of Amaranthus cruentus.

Marcele believes that control of weevil pests should thus be the focus of future pest and pathogen management strategies and breeding programmes in A. cruentus.  

“Knowledge gained in my thesis will hopefully aid in the development of future cultivation practices, integrated pest/pathogen management programmes, as well as for the registration of crop protection products for A. cruentus,” Marcele added.

Research Contributes to Food Security from University of the Free State on Vimeo.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept